Coronavirus tested in France HEMO2life

By | June 29, 2020
Coronavirus drug tested in France HEMO2life

HEMO2life has already been tested in the United States in people with cerebral hypoxia.
  In France, 10 patients agreed to a study with a that should help people with severe complications of coronavirus, reports Le Express.
  The is based on the hemoglobin of marine worms and is capable of delivering 40 times more oxygen than human hemoglobin.
 
Scientists believe the blood of Arenicolaes sea worms is new hope for helping serious cases of coronavirus, the publication said.
  Already 10 patients with COVID-19 agreed to test the. All of them will be given a solution intended for patients suffering from acute respiratory distress syndrome (ARDS – a life-threatening inflammatory lesion of the lungs). This solution is made from the hemoglobin of a sea worm.
 
A product called HEMO2life has already been tested in the United States in people with cerebral hypoxia.
 
The manufacturer of has already stated that, if successful, it is ready to immediately provide 5 thousand doses of the solution and can produce an additional 15 thousand doses in a short period of time.
  Previously, a against coronavirus was already tested in France.
  Recall that Russian scientists reported the creation of three that could theoretically be effective in treating coronavirus.